| Drug Name |
Oxytetracycline |
| Drug ID |
BADD_D01650 |
| Description |
A tetracycline analog isolated from the actinomycete streptomyces rimosus and used in a wide variety of clinical conditions. |
| Indications and Usage |
Oxytetracycline is indicated for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae. |
| Marketing Status |
Discontinued |
| ATC Code |
D06AA03; G01AA07; J01AA06; S01AA04 |
| DrugBank ID |
DB00595
|
| KEGG ID |
C06624
|
| MeSH ID |
D010118
|
| PubChem ID |
54675779
|
| TTD Drug ID |
D0J2NK
|
| NDC Product Code |
24507-001; 51671-0002; 24507-002; 70831-101; 82403-001; 54509-0001; 60264-115; 60264-110; 81157-0620 |
| Synonyms |
Oxytetracycline | Hydroxytetracycline | Geomycin | Oxyterracin | Oxyterracine | Oxytetracid | Oxytetracycline Calcium | Oxytetracycline Dihydrate | Oxytetracycline Hydrochloride | Oxytetracycline Monohydrochloride | Oxytetracycline Sulfate (2:1) | Oxytetracycline, (4a beta,5 beta,5a beta,12a beta)-Isomer | Oxytetracycline, (5 beta)-Isomer | Oxytetracycline, Anhydrous | Oxytetracycline Anhydrous | Oxytetracycline, Calcium (1:1) Salt | Oxytetracycline, Disodium Salt, Dihydrate | Oxytetracycline, Sodium Salt | Terramycin | Bisolvomycin |
